Pathogen: Monkeypox virus

Girometti

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox

Grau-Echevarria

Spain
|
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

EPOXI

Belgium France Germany Italy Norway Portugal Spain The Netherlands
|
2024-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Tecovirimat

COVA / RestPlus

The Netherlands
|
2022-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Healthcare workers
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Moderna mRNA-1769-P101

United Kingdom
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • mRNA-1769

Chromy

Austria
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

CEME-22

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

Zuiani

United Kingdom United States of America
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • BNT166a

Mpox-Cohort

Italy
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • PrEP users
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Amsterdam Cohort Studies

The Netherlands
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Primary care
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination

Agunbiade

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN